M-89 is a potent and selective small molecule inhibitor of the menin-MLL interaction, exhibiting a 1.4 nM Kd for menin. It is a valuable research tool for investigating MLL-rearranged leukemia mechanisms in both cellular and animal models, supporting the development of targeted therapeutics.